What is the emergency management of naphthalene poisoning, including treatment of acute hemolytic anemia and methemoglobinemia?

Emergency Management of Naphthalene Poisoning

Naphthalene poisoning requires immediate supportive care with red blood cell transfusions for severe hemolysis, and methylene blue (1-2 mg/kg IV) for methemoglobinemia >20-30%, but methylene blue is absolutely contraindicated in G6PD deficiency—use exchange transfusion or ascorbic acid instead. 1, 2

Immediate Assessment and Stabilization

Contact your regional poison control center immediately (US: 1-800-222-1222) for expert toxicology guidance, as specialized consultation improves outcomes in complex poisoning cases. 3

Critical Initial Actions:

• Secure airway and provide 100% oxygen to maintain tissue oxygenation, regardless of pulse oximetry readings (which will be falsely low at 84-85% due to methemoglobinemia). 4, 5
• Do NOT induce vomiting or delay treatment waiting for confirmatory testing—naphthalene toxicity presents 48-96 hours post-exposure with acute hemolysis and methemoglobinemia. 6, 5
• Obtain immediate labs: CBC, reticulocyte count, methemoglobin level, indirect bilirubin, LDH, haptoglobin, renal function, and G6PD screening before any methylene blue administration. 2, 1

Management of Acute Hemolytic Anemia

Transfuse packed red blood cells for symptomatic anemia or hemoglobin <7 g/dL, as naphthalene causes severe acute intravascular hemolysis that can persist for 5+ days post-ingestion. 7, 5, 8

Hemolysis Management:

• Maintain aggressive IV hydration to prevent acute tubular necrosis from hemoglobinuria (urine will be dark brown). 5, 8
• Monitor for renal failure with serial creatinine and urine output—naphthalene commonly causes renal dysfunction from hemoglobin precipitation. 1, 5
• Expect prolonged hemolysis: Clinical parameters may not improve until 5+ days post-exposure despite aggressive treatment. 7

Management of Methemoglobinemia

For Patients WITHOUT G6PD Deficiency:

Administer methylene blue 1-2 mg/kg IV over 5 minutes if methemoglobin level is >20-30% or patient is symptomatic (cyanosis, altered mental status, cardiovascular instability). 4, 1

Critical methylene blue precautions:

• Never exceed 7 mg/kg total cumulative dose—toxicity occurs above this threshold. 2
• Screen for SSRI/serotonergic medication use—methylene blue can precipitate life-threatening serotonin syndrome. 2
• Avoid repeated dosing due to rebound worsening of methemoglobinemia. 2
• Use extreme caution in pregnancy due to teratogenicity concerns. 2

For Patients WITH G6PD Deficiency:

Methylene blue is absolutely contraindicated—it will cause severe, potentially fatal hemolytic anemia in G6PD-deficient patients. 4, 2, 1

Alternative treatments for G6PD deficiency:

• Exchange transfusion is the treatment of choice for severe methemoglobinemia when methylene blue cannot be used. 4, 2
• Ascorbic acid (vitamin C) 1-2 grams IV can be administered, though its effect is slow (requires multiple doses over several hours) and should not be relied upon as monotherapy in life-threatening situations. 4, 5, 8
• Hyperbaric oxygen has been used but methemoglobin reduction is delayed up to several hours, making it impractical in cardiovascular collapse. 4

Adjunctive Therapies

N-acetylcysteine has been used in multiple case reports of naphthalene poisoning, though evidence for efficacy is limited to case series. 7, 5, 8

Ascorbic acid can be added as adjunctive therapy in all patients (not contraindicated in G6PD deficiency), though it should not replace definitive treatment. 7, 5, 8

Critical Pitfalls to Avoid

• Never administer methylene blue without G6PD screening when time permits—this is the most dangerous error in naphthalene poisoning management. 2, 1
• Do not rely on initial pulse oximetry—readings will be falsely low (84-85%) and do not reflect true oxygenation status. 5
• Do not underestimate severity in G6PD deficiency—these patients have markedly worse outcomes with higher morbidity and mortality. 1, 9
• Do not discharge early—hemolysis and methemoglobinemia can persist or worsen for 5+ days post-exposure. 7
• Beware false-negative G6PD screening during acute hemolysis—reticulocytosis can mask deficiency. 9

Monitoring Requirements

• Continuous cardiac monitoring for dysrhythmias secondary to severe anemia and methemoglobinemia. 1
• Serial methemoglobin levels every 4-6 hours until consistently <5%. 1
• Daily CBC, reticulocyte count, bilirubin, LDH to track hemolysis. 7, 8
• Strict intake/output monitoring with urine color assessment for hemoglobinuria. 5, 8